Nibec Co., Ltd. logo

Nibec Co., Ltd. (138610)

Market Open
11 Aug, 06:30
KRX SM KRX SM
17,320. 00
+220
+1.2865%
464.66B Market Cap
- P/E Ratio
- Div Yield
2,714 Volume
- Eps
17,100
Previous Close
Add Transaction
Day Range
16,970 17,420
Year Range
11,230 54,300
Want to track 138610 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

138610 trading today higher at ₩17,320, an increase of 1.2865% from yesterday's close, completing a monthly increase of 2.0625% or ₩350. Over the past 12 months, 138610 stock lost -53.5034%.
138610 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

138610 Chart

People also search for

Samsung Biologics Co., Ltd.
1,588,000
+1.211%
Celltrion Inc.
204,500
+1.7413%
ALTEOGEN Inc.
340,500
-2.1552%
Sk Biopharmaceuticals Co., Ltd.
90,600
+2.1421%
ABL Bio Inc.
92,300
-1.3889%

Nibec Co., Ltd. (138610) FAQ

What is the stock price today?

The current price is ₩17,320.00.

On which exchange is it traded?

Nibec Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 138610.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 464.66B.

Has Nibec Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Nibec Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
- CEO
KRX SM Exchange
- ISIN
South Korea Country
96 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

NIBEC Co., Ltd., founded in 2004 and based in Jincheon-eup, South Korea, is at the forefront of developing innovative solutions for tissue regeneration. The company is dedicated to the research and development, manufacture, and sale of cutting-edge tissue regeneration devices. Leveraging advanced technologies, NIBEC focuses on the creation of peptide-based fusion products, regenerative biomaterials, cosmetics, and oral care products. Its commitment to improving health and wellbeing is underscored by its extensive product portfolio, which is designed to meet the needs of patients and consumers in South Korea and beyond. The company's relentless pursuit of innovation and excellence in the field of biotechnology has positioned it as a leader in regenerative medicine, offering solutions that enhance the body's natural healing process.

Products and Services

  • Peptide-based Fusion Products: NIBEC's peptide-based fusion products are designed with the latest technology to support tissue regeneration. These products harness the power of peptides to promote the body's natural healing processes, making them essential in the recovery of damaged tissues.
  • Regenerative Biomaterials: The company offers a range of biomaterials aimed at aiding the regeneration of tissues. Made from biocompatible materials, these products facilitate various medical procedures and treatments by providing scaffolds that support cell growth and tissue repair.
  • Cosmetics: Leveraging its expertise in peptide technology and regenerative medicine, NIBEC manufactures cosmetics that are not only designed to enhance beauty but also to promote skin health. These cosmetic products incorporate bioactive ingredients that support skin regeneration and repair.
  • Oral Care Products: NIBEC's oral care products are developed to maintain oral hygiene and health. Featuring innovative formulations, these products help in the prevention of dental diseases, ensuring overall oral wellness.

Contact Information

Address: Iwol electricity-electronic Agro-industrial Complex
Phone: 82 4 3532 7458